Research News and Research

RSS

House votes to fix Medicaid glitch

The House easily passed legislation that would fix a Medicaid "glitch" created by the health law that would have allowed up to 3 million middle-class couples earning as much as $64,000 onto the already struggling Medicaid rolls starting in 2014. The House also voted to adjust a definition that determines eligibility for certain health care programs.

29 Oct 2011

Cancer symposium at Georgetown focuses on 'Linking Policy to the Patient'

The Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center announces a three-part symposium, titled "Fighting a Smarter War Against Cancer: Linking Policy to the Patient," to be held Thursday, December 1 through Saturday, Dec. 3, 2011 on the campuses of Georgetown University and Georgetown University Law Center in Washington, D.C.

29 Oct 2011

Global Health Technologies Coalition blog reports on health research projects in Kenya

In a post in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC's Kim Lufkin reports on her travels to Kenya this month "to visit global health research projects and see the impact on people in the country," writing, "Although we visited a range of projects, I was left with the lasting impression that much of this research is so close to producing new health tools that can lead to amazing innovations in public health," including "the first ever malaria vaccine, gels women can use to protect themselves from HIV, and new drugs for neglected diseases that affect the poorest of the poor."

29 Oct 2011

Researcher's compound disables bacteria instead of killing them

After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?

29 Oct 2011

Research roundup: Medicaid's long-term care bill; work-based coverage and the health law

This study examined Medicare data on beneficiaries diagnosed with colorectal cancer between 1995 and 2005 who ranged from 67 to 85 years old. The authors found, "Medicare beneficiaries with colon cancer had better outcomes if they had more primary care utilization before diagnosis. Even within this universally insured population, 28% of Medicare beneficiaries with colon cancer had no or only 1 contact with primary care physicians in the 3 to 27 months before the diagnosis.

29 Oct 2011

ZIOPHARM reports promising preclinical data with palifosfamide in pediatric sarcoma model

ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced the presentation of promising preclinical data with palifosfamide in a pediatric sarcoma model.

29 Oct 2011

Researchers identify compound that inhibits viral replication

Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.

29 Oct 2011

Scientists identify nicotinamidase enzyme as new drug target for Leishmaniasis

IRD scientist and their research partners recently identified the key role of nicotinamidase, an enzyme in the parasite Leishmania, essential for its survival but which does not exist in humans. The pathogen is incapable of developing in mammals In the absence of this enzyme. Specific targeting of this enzyme could lead to more effective ways of controlling this neglected tropical disease.

29 Oct 2011

Obama ahead in campaign cash race

The National Journal reports that President Barack Obama is outpacing the GOP candidates in fundraising from the health industry.

29 Oct 2011

NYUCN to study 'Test and Linkage to Care Among Injecting Drug Users Kenya'

New York University College of Nursing (NYUCN) received a five-year, $4,161,665.00 grant from the National Institute of Health's National Institute on Drug Abuse (NIH/NIDA) to research "Test and Linkage to Care Among Injecting Drug Users (TLC_IDU) Kenya."

29 Oct 2011

Research breakthrough in lung regeneration

Scientists at A*STAR'S Genome Institute of Singapore (GIS) and Institute of Molecular Biology (IMB), have made a breakthrough discovery in the understanding of lung regeneration. Their research showed for the first time that distal airway stem cells (DASCs), a specific type of stem cells in the lungs, are involved in forming new alveoli to replace and repair damaged lung tissue, providing a firm foundation for understanding lung regeneration.

29 Oct 2011

Tanzania becomes first country to use self-destructing syringes; designer hopes others will follow suit

"Tanzania is to become the first country in the world to move exclusively to using syringes that self-destruct after a British entrepreneur played the health minister undercover footage of children being injected with used needles," the Guardian reports.

29 Oct 2011

Free computer application accurately models human motion

There are 640 muscles in the human body, or maybe it is 639. Or maybe it is 850. Or 656. It all depends on whom you ask. In any case, it is a lot. Stanford bioengineer Scott Delp knows; he has programmed almost every one into his latest work, OpenSim, a software application that helps medical professionals and bioengineers study, diagnose and correct abnormalities in how people move.

29 Oct 2011

Pall, NIBRT co-host master class on single-use systems in manufacturing of biopharmaceuticals

Pall Life Sciences and the National Institute for Bioprocessing Research and Training (NIBRT) in Ireland recently co-hosted a master class on the use of single-use systems in the development and manufacturing of biopharmaceuticals.

From Pall Corporation 29 Oct 2011

Food aid vouchers are faster, cheaper alternative than shipping food aid abroad

In this New York Times opinion piece, author Tina Rosenberg reports on the use of food vouchers by some aid organizations in Somalia, highlighting the efforts of World Concern, "a Seattle-based Christian humanitarian group, and its Somali partner, the African Rescue Committee, [which] provide 1,800 families every two weeks with rice, beans, cooking oil, salt and sugar for their tea."

29 Oct 2011

Number of polio cases in Pakistan exceeds total number reported in three other endemic countries, report says

According to a report published earlier this month in Virology Journal by a team at the bioinformatics laboratory of the Centre for Excellence in Molecular Biology (CEMB) in Lahore, Pakistan, that country is reporting more polio cases than Nigeria, India and Afghanistan -- the three other countries where the disease is endemic -- combined, SciDev.Net reports.

29 Oct 2011

Study: Reduced secretion of beta-amyloid signals beginning of Alzheimer's

For decades the amyloid hypothesis has dominated the research field in Alzheimer's disease. The theory describes how an increase in secreted beta-amyloid peptides leads to the formation of plaques, toxic clusters of damaged proteins between cells, which eventually result in neurodegeneration. Scientists at Lund University, Sweden, have now presented a study that turns this premise on its head.

29 Oct 2011

NYUCN to study 'Midwifery: Primary Care and Health Literacy Program Enhancement'

New York University College of Nursing (NYUCN) received a three -year, $1,002,318.00 grant from the Human Resources & Services Administration (HRSA) to research "Midwifery: Primary Care and Health Literacy Program Enhancement."

29 Oct 2011

FDA approves Medtronic's LGS IDE for clinical trial to treat Type 1 diabetes

In our continued commitment to develop an artificial pancreas, Medtronic, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) to conduct a pivotal in-home clinical trial protocol for the ASPIRE study of the MiniMed Paradigm System featuring Low Glucose Suspend (LGS) automation.

From Medtronic 29 Oct 2011

Sorin Group third quarter revenues decrease 2.1% to €171.4 million

Sorin Group: Revenues of €171.4 million, a 2.1% decline (-4.9% as reported) over the same period last year.

29 Oct 2011

Research News and Research

House votes to fix Medicaid glitch

Cancer symposium at Georgetown focuses on 'Linking Policy to the Patient'

Global Health Technologies Coalition blog reports on health research projects in Kenya

Researcher's compound disables bacteria instead of killing them

Research roundup: Medicaid's long-term care bill; work-based coverage and the health law

ZIOPHARM reports promising preclinical data with palifosfamide in pediatric sarcoma model

Researchers identify compound that inhibits viral replication

Scientists identify nicotinamidase enzyme as new drug target for Leishmaniasis

Obama ahead in campaign cash race

NYUCN to study 'Test and Linkage to Care Among Injecting Drug Users Kenya'

Research breakthrough in lung regeneration

Tanzania becomes first country to use self-destructing syringes; designer hopes others will follow suit

Free computer application accurately models human motion

Pall, NIBRT co-host master class on single-use systems in manufacturing of biopharmaceuticals

Food aid vouchers are faster, cheaper alternative than shipping food aid abroad

Number of polio cases in Pakistan exceeds total number reported in three other endemic countries, report says

Study: Reduced secretion of beta-amyloid signals beginning of Alzheimer's

NYUCN to study 'Midwifery: Primary Care and Health Literacy Program Enhancement'

FDA approves Medtronic's LGS IDE for clinical trial to treat Type 1 diabetes

Sorin Group third quarter revenues decrease 2.1% to €171.4 million

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News